FIELD: medicine.
SUBSTANCE: method involves calculating life duration in months from a formula being linear combination of several variables defined as morphological tumor parameters like carcinoma differentiation degree, tumor cell area, mean tumor cell nuclei ploidity level, p53 expression level, PCNA expression level and progesterone receptors expression level.
EFFECT: high accuracy of survival period prognosis.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
| METHOD FOR PREDICTING SEROUS OVARIAN CARCINOMA PATIENTS SURVIVAL PERIOD IN CLIMACTERIC PERIOD AND POSTMENOPAUSE | 2005 |
|
RU2291435C1 |
| PREDICTION METHOD OF LIFE DURATION IN PATIENTS WITH MESONEPHROID OVARIAN CARCINOMA | 2008 |
|
RU2357672C1 |
| LIFE SPAN PREDICTION METHOD FOR PATIENTS SUFFERING FROM MUCINOUS OVARIAN CARCINOMA | 2008 |
|
RU2354303C1 |
| METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH HEPATICCELLULAR CARCINOMA | 2001 |
|
RU2207573C2 |
| METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS RELAPSING OVARIAN CARCINOMA | 2005 |
|
RU2297788C1 |
| METHOD FOR PREDICTION OF RECURRENT OVARIAN CARCINOMA | 2013 |
|
RU2530556C1 |
| METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS AND ENDOMETRIOID OVARIAN CARCINOMA | 2003 |
|
RU2263912C2 |
| METHOD FOR PREDICTING LIFE DURATION OF PATIENTS SUFFERING FROM CHOLANGIOGENIC HEPATIC CARCINOMA | 2001 |
|
RU2202957C1 |
| METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH SEROSAL OVARIAN CANCER | 2005 |
|
RU2299018C1 |
